REPLIMUNE GROUP INC's ticker is REPL and the CUSIP is 76029N106. A total of 134 filers reported holding REPLIMUNE GROUP INC in Q4 2022. The put-call ratio across all filers is 0.01 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $11,910,880 | +887.6% | 437,900 | +527.1% | 0.04% | +700.0% |
| Q3 2022 | $1,206,000 | -63.3% | 69,825 | -62.8% | 0.01% | -64.3% |
| Q2 2022 | $3,283,000 | -77.4% | 187,800 | -78.0% | 0.01% | -75.9% |
| Q1 2022 | $14,515,000 | +57.4% | 854,800 | +151.3% | 0.06% | +56.8% |
| Q4 2021 | $9,219,000 | +48.8% | 340,200 | +110.9% | 0.04% | +32.1% |
| Q2 2021 | $6,197,000 | -67.0% | 161,300 | -73.8% | 0.03% | -68.2% |
| Q1 2021 | $18,772,000 | -37.3% | 615,278 | -21.6% | 0.09% | -39.7% |
| Q4 2020 | $29,952,000 | +31.8% | 785,100 | -20.4% | 0.15% | +25.9% |
| Q3 2020 | $22,719,000 | – | 986,916 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 3,001,319 | $51,352,568 | 47.17% |
| Atlas Venture Life Science Advisors, LLC | 2,098,300 | $35,901,913 | 5.56% |
| Redmile Group, LLC | 4,163,922 | $71,244,705 | 3.39% |
| Nan Fung Group Holdings Ltd | 184,739 | $3,160,884 | 2.56% |
| GREAT POINT PARTNERS LLC | 638,495 | $10,924,649 | 1.99% |
| ACUTA CAPITAL PARTNERS, LLC | 150,000 | $2,566,500 | 1.72% |
| Ghost Tree Capital, LLC | 250,000 | $4,277,500 | 1.41% |
| Altium Capital Management LP | 155,000 | $2,652,050 | 1.38% |
| ACUTA CAPITAL PARTNERS, LLC | 1,000 | $1,766,000 | 1.18% |
| Camber Capital Management LP | 2,000,000 | $34,220 | 1.13% |